Urwashi kumar

About

Researcher with 8 years of work experience in the field of Cancer Biology, Cell Biology, Proteomics, Protein Biology, Biochemistry, Structural Biology, and Bioinformatics in several esteemed National (D Y Patil University, NIPGR, AIIMS, IOP, ICMR) and International (ICGEB) Organizations. My ongoing Ph.D in the School of Biotechnology and Bioinformatics, D Y Patil Deemed to be University, helped me to gain extensive knowledge of mammalian in-vitro culture methods, Drug repurposing, Drug toxicity analysis, Functional analysis of pharmaceutical and therapeutic molecules, and Bioinformatic tools. I achieved state-of-the-art experimental and analytical experience in the clinical settings of the Malaria Vaccine Development Unit of Malaria lab, ICGEB in a European Commission-funded project. Demonstrated record of scientific achievements through consistent publication record (H index = 2, with 97 citations) in good journals such as Journal of Infectious Diseases, Naunyn-Schmiedeberg's Archives of Pharmacology, Applied Water Science and Bulletin of the National Research Centre. A well-trained biotechnologist with diverse experience on the bench across different research themes ranging from Malaria to Cancer and other infectious diseases. An individual with a strong commitment and innovative mindset. Have the ability to work on diverse projects and to educate people aiming at a breakthrough basic and applied research in the field of endemic as well as global diseases.

Employment

• D Y Patil University School of Biotechnology and Bioinformatics Phd scholar
  2019 - Present
• International Centre for Genetic Engineering and Biotechnology Research Assistant
  2007 - 2011

Education

• Sam Higginbottom University of Agriculture Technology and Sciences MSc

Projects & Funding

Projects & funding information is unavailable.

Publications (5)

• Exploring the repurposing potential of telmisartan drug in breast cancer
  Anti-Cancer Drugs 2023 DOI: 10.1097/cad.0000000000001509
  +Save
• Drug repurposing—an emerging strategy in cancer therapeutics
  Naunyn-Schmiedeberg's Archives of Pharmacology 2022 DOI: 10.1007/s00210-022-02263-x
  +Save
• One of the 5-aminosalicylates drug, mesalamine as a drug repurposing lead against breast cancer
  Bulletin of the National Research Centre 2022 DOI: 10.1186/s42269-022-00939-1
  +Save
• Comparative bacterial degradation and detoxification of model and kraft lignin from pulp paper wastewater and its metabolites
  Applied Water Science 2017 DOI: 10.1007/s13201-015-0288-9
  +Save
• Improved Pregnancy Outcomes in Women Exposed to Malaria With High Antibody Levels Against Plasmodium falciparum
  The Journal of Infectious Diseases 2013 DOI: 10.1093/infdis/jit083
  +Save